TACTILE SYSTEMS TECHNOLOGY INC
TCMDNasdaq
$28.74
↓ -2.3%Jul 17 close · end-of-day
Price
1Y↑ +193.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$648.4M
Enterprise Value
$573.4M
P/E
33.0
P/S
1.9
P/B
3.0
EV/EBITDA
14.8
PEG
—
FCF Yield
6.0%
Dividend Yield
—
Revenue (TTM)
$343.5M
Net Income (TTM)
$20.3M
Free Cash Flow (TTM)
$39.2M
Gross Margin
76.4%
Operating Margin
9.4%
Net Margin
5.9%
ROE
9.3%
ROIC
13.3%
Debt / Equity
0.0
Net Cash
$75.0M
Return 1Y
+187.1%
Company profile
Tactile Systems Technology, Inc. engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, venous insufficiency, and venous leg ulcers. AffloVest is a portable high frequency chest wall oscillation test for the. treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis.
- CEO
- Daniel L. Reuvers
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 980
- Headquarters
- Minnesota
- Website
- tactilemedical.com
Management & directors
- Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
- Burns KristieSr. VP Mktg & Clinical Affairs
- Dodd Sheri LouiseChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
TCMD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$75.3M↑ +22.8%
Diluted EPS-$0.08↓ -38.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $187.1M | $208.1M | $246.8M | $274.4M | $293.0M | $329.5M |
| Gross profit | $132.8M | $148.2M | $176.0M | $195.1M | $216.7M | $250.1M |
| Operating income | -$3.6M | -$1.8M | -$12.8M | $18.0M | $22.2M | $29.3M |
| Net income | -$620,000.00 | -$11.8M | -$17.9M | $28.5M | $17.0M | $19.1M |
| Diluted EPS | -$0.03 | -$0.60 | -$0.89 | $1.23 | $0.70 | $0.82 |
| Operating cash flow | $2.8M | $2.6M | $5.2M | $35.9M | $40.7M | $42.8M |
| Free cash flow | $735,000.00 | $528,000.00 | $3.4M | $33.5M | $38.3M | $40.4M |
| Gross margin | 71.0% | 71.2% | 71.3% | 71.1% | 74.0% | 75.9% |
| Operating margin | -1.9% | -0.8% | -5.2% | 6.6% | 7.6% | 8.9% |
| Net margin | -0.3% | -5.7% | -7.2% | 10.4% | 5.8% | 5.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $73.2M | $73.1M | $85.6M | $61.3M | $78.9M | $85.8M | $103.6M | $75.3M |
| Gross profit | $54.1M | $54.8M | $64.4M | $45.3M | $58.8M | $65.0M | $81.0M | $57.6M |
| Operating income | $5.8M | $6.8M | $12.5M | -$4.5M | $4.1M | $11.0M | $18.8M | -$1.5M |
| Net income | $4.3M | $5.2M | $9.7M | -$3.0M | $3.2M | $8.2M | $10.6M | -$1.8M |
| Diluted EPS | $0.18 | $0.21 | $0.40 | -$0.13 | $0.14 | $0.36 | $0.45 | -$0.08 |
| Operating cash flow | $13.1M | $10.3M | $16.3M | $417,000.00 | $14.8M | $10.3M | $17.3M | -$339,000.00 |
| Free cash flow | $12.6M | $9.3M | $15.9M | $38,000.00 | $14.4M | $9.2M | $16.8M | -$1.2M |
| Gross margin | 73.9% | 75.0% | 75.2% | 74.0% | 74.5% | 75.8% | 78.2% | 76.5% |
| Operating margin | 8.0% | 9.3% | 14.6% | -7.4% | 5.2% | 12.8% | 18.1% | -2.0% |
| Net margin | 5.9% | 7.1% | 11.4% | -4.9% | 4.1% | 9.6% | 10.3% | -2.3% |
Company news
Jun 29, 2026
Jun 2, 2026
May 20, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-11 | Birkemeyer Elaine M.· CHIEF FINANCIAL OFFICER | Sale | 4,631 | $24.49 | $113,403.93 | filing |
| 2026-05-06 | Asbury Valerie L. | Award | 6,521 | $0.00 | $0.00 | filing |
| 2026-05-06 | Huggenberger Raymond | Award | 6,521 | $0.00 | $0.00 | filing |
| 2026-05-06 | King Laura G. | Award | 6,521 | $0.00 | $0.00 | filing |
| 2026-05-06 | Pearson Andrea | Award | 6,521 | $0.00 | $0.00 | filing |
| 2026-05-06 | Shafer David Brent | Award | 6,521 | $0.00 | $0.00 | filing |
| 2026-05-06 | DIERSEN CARMEN L | Award | 6,521 | $0.00 | $0.00 | filing |
| 2026-05-06 | BURKE WILLIAM W | Award | 6,521 | $0.00 | $0.00 | filing |
| 2026-05-06 | Washington Boyd Vindell | Award | 6,521 | $0.00 | $0.00 | filing |
| 2026-03-09 | Pearson Andrea | Award | 852 | $0.00 | $0.00 | filing |
| 2026-02-24 | Dodd Sheri Louise· Chief Executive Officer | Sale | 10,993 | $28.94 | $318,144.02 | filing |
| 2026-02-24 | Birkemeyer Elaine M.· CHIEF FINANCIAL OFFICER | Sale | 7,701 | $28.94 | $222,880.03 | filing |
| 2026-02-24 | Burns Kristie· Sr. VP Mktg & Clinical Affairs | Sale | 6,246 | $28.94 | $180,764.24 | filing |
| 2026-02-23 | Dodd Sheri Louise· Chief Executive Officer | Sale | 14,703 | $28.28 | $415,839.07 | filing |
| 2026-02-23 | Birkemeyer Elaine M.· CHIEF FINANCIAL OFFICER | Sale | 5,322 | $28.28 | $150,520.53 | filing |
| 2026-02-23 | Burns Kristie· Sr. VP Mktg & Clinical Affairs | Sale | 4,279 | $28.28 | $121,021.67 | filing |
| 2026-02-23 | Dodd Sheri Louise· Chief Executive Officer | Sale | 537 | $28.69 | $15,406.05 | filing |
| 2026-02-23 | Birkemeyer Elaine M.· CHIEF FINANCIAL OFFICER | Sale | 196 | $28.69 | $5,623.08 | filing |
| 2026-02-23 | Burns Kristie· Sr. VP Mktg & Clinical Affairs | Sale | 160 | $28.69 | $4,590.29 | filing |
| 2026-02-20 | Dodd Sheri Louise· Chief Executive Officer | Award | 19,751 | $0.00 | $0.00 | filing |
| 2026-02-20 | Dodd Sheri Louise· Chief Executive Officer | Award | 28,216 | $0.00 | $0.00 | filing |
| 2026-02-20 | Burns Kristie· Sr. VP Mktg & Clinical Affairs | Award | 3,490 | $0.00 | $0.00 | filing |
| 2026-02-20 | Burns Kristie· Sr. VP Mktg & Clinical Affairs | Award | 4,058 | $0.00 | $0.00 | filing |
| 2026-02-20 | Burns Kristie· Sr. VP Mktg & Clinical Affairs | Award | 7,123 | $0.00 | $0.00 | filing |
| 2026-02-20 | Birkemeyer Elaine M.· CHIEF FINANCIAL OFFICER | Award | 3,579 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.